Navigation Links
RAPS Offers New International Regulatory Affairs Certification - RAC (GS)
Date:4/7/2009

New RAC Credential Focuses on General Scope of Regulatory Practice, International Standards

ROCKVILLE, Md., April 7 /PRNewswire-USNewswire/ -- The Regulatory Affairs Professionals Society (RAPS) has announced its newest Regulatory Affairs Certification (RAC), the RAC General Scope (GS). The RAC (GS) credential denotes knowledge related to the general scope of practice of regulatory professionals in the healthcare product sector, regardless of geographic location or in which regions they may be involved. The RAC is the only professional certification specifically for healthcare product regulatory professionals. More than 5,000 have earned the credential to date.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070314/DCW091LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh//DC89286)

The RAC (GS) joins RAPS' three established, regional RAC certifications covering regulations specific to the United States (US), the European Union (EU) and Canada (CAN), respectively. Like those credentials, the RAC (GS) signifies vital regulatory professional abilities and commitment to excellence in the field. Unlike the three regional RAC certifications, the RAC (GS) does not pertain to a specific geographic region.

"The RAC has become a highly respected standard in the regulatory profession," said RAPS Executive Director Sherry Keramidas, PhD, CAE. "As the regulatory profession has grown globally and regions such as Asia and Latin America have seen more healthcare product development, the need for a new RAC certification covering regulatory material beyond North America or Europe has become increasingly apparent."

RAC (GS) candidates must take an exam covering knowledge of the full product lifecycles for medical devices, IVDs, pharmaceutical and medicinal products, as well as international guidelines and standards such as those from ICH, GHTF, WHO and ISO. The first exam will be offered worldwide beginning in October.

For more information, visit www.raps.org/rac.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. As regulatory professionals, RAPS members perform vital work in all areas of the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession as a whole by providing education and training, certification, professional standards, research, knowledge-sharing, publications, networking and career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS.org


'/>"/>
SOURCE Regulatory Affairs Professionals Society (RAPS)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Authority Offers Expedient, Web-Based Medicaid Enrollment Service
2. Physicians Coalition for Injectable Safety Says There are No Substitutes for Cosmetic Injections, Offers Solutions
3. Magazines.com Offers Professional Discounted Subscriptions to Healthcare Publications
4. Whitepaper Shines Light on Administrative Waste: Offers Practical Steps for Cutting Healthcare Costs through Existing Infrastructure, Collaboration
5. Hard To Treat Diseases (HTDS) Offers Hepatitis A Vaccine in India
6. User Centric Offers New Service, Usability Diagnostics, to Measure HIT Usability
7. Blood, Marrow Drive Offers Hope for Baseball Player, 15
8. New Mobile Mammography Unit Offers Residents of Rural Northern Louisiana First-Ever Access to Free Breast Cancer Screening Exams
9. New Mobile Mammography Unit Offers Residents of Rural Northern Louisiana First-Ever Access to Free Breast Cancer Screening Exams
10. HealthForumOnline Offers New Online CE Course on Working with Transgender Individuals
11. PGD Technology Offers More Than Designer Babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... From May ... Chicago, IL, offering EarQ members the unique opportunity to learn more about Signia’s technology ... independent practice growth. , “It is our priority to see practices succeed in this ...
(Date:5/6/2016)... San Diego, CA (PRWEB) , ... May 06, 2016 , ... ... of Companies, has been family-owned and operated for over 35 years. Maintaining core values ... community has driven their success and made them a leading name in San Diego ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... and David Konur, CEO of Cardiovascular Institute of the South announced today that ... performing a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... overall select performance in the industry’s gold standard KLAS Performance Report, ... Epic Consulting report assessed organizations that specialize in consulting services for electronic health ...
(Date:5/5/2016)... ... May 05, 2016 , ... Florida Hospital Pepin ... atrial fibrillation (A-Fib) an alternative to long-term warfarin medication with the newly approved ... April of 2015, Florida Hospital Pepin Heart Institute doctors successfully implanted the Watchman ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... DUBLIN , May 5, 2016 ... for PET Imaging in Top 5 EU Markets"  report to ... This report provides information on the current Positron Emission ... Five European Markets (T5 EU), which includes France ... , Spain and the ...
(Date:5/4/2016)... Holdings (NYSE: CODI ) ("CODI," "we," "our" ... businesses, announced today its consolidated operating results for the ... Quarter 2016 Highlights , Generated Cash Flow Available ... $13.6 million for the first quarter of 2016; ... first quarter of 2016; , Paid a first ...
(Date:5/4/2016)... -- Yissum Research Development Company of ... it had signed an exclusive world-wide licensing and research ... protein degradation and immunomodulatory drugs for cancer and immune ... representing first-in-class therapy for hematologic and solid malignancies. Financial ... The novel technology was developed by Yinon Ben-Neriah ...
Breaking Medicine Technology: